Effect of Treatment with Progestins and Antiplatelet Agents on IVF in Women with Adenomyosis and Recurrent Implantation Failure

<b>Background:</b> This prospective study aims to identify the effect of the dienogest 2 mg/day and aspirin 150 mg/day combined treatment for two months before frozen ET on the assisted reproduction outcome in women with adenomyosis and recurrent implantation failure (RIF). <b>Meth...

Full description

Saved in:
Bibliographic Details
Main Authors: Irina Pacu, Nikolaos Zygouropoulos, Giorgia Zampieri, Aida Petca, Mircea Octavian Poenaru, Cringu Antoniu Ionescu
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/15/1/30
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841549272105877504
author Irina Pacu
Nikolaos Zygouropoulos
Giorgia Zampieri
Aida Petca
Mircea Octavian Poenaru
Cringu Antoniu Ionescu
author_facet Irina Pacu
Nikolaos Zygouropoulos
Giorgia Zampieri
Aida Petca
Mircea Octavian Poenaru
Cringu Antoniu Ionescu
author_sort Irina Pacu
collection DOAJ
description <b>Background:</b> This prospective study aims to identify the effect of the dienogest 2 mg/day and aspirin 150 mg/day combined treatment for two months before frozen ET on the assisted reproduction outcome in women with adenomyosis and recurrent implantation failure (RIF). <b>Methods:</b> Patients were selected based on specific criteria and divided into two groups (with and without treatment). Preimplantation biochemical parameters and ultrasonographic features (endometrial thickness, uterine peristalsis, and junctional zone thickness) were compared with pregnancy rate in a non-natural cycle frozen embryo transfer technique. A comparison between the two study groups indicated an increased successful implantation rate and clinical pregnancy rate (25% vs. 7.4%). <b>Results</b>: These results were attributed to the reduced uterine peristalsis and the reduction in thickness of the junctional zone following treatment. Available data were limited due to the nature of the study though maximal effort was exerted for the selected patients between groups to be as demographically similar and free from other potential pathology that may affect the results. <b>Conclusions:</b> In conclusion, it appears that the above stated treatment improves outcomes in women with adenomyosis and RIF; the parameters used may provide an insight as to the reasons why this occurs, though an explanation of the molecular mechanisms is still elusive.
format Article
id doaj-art-6561a3a900344ef1beaa8d4eaa1861d2
institution Kabale University
issn 2075-4418
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj-art-6561a3a900344ef1beaa8d4eaa1861d22025-01-10T13:16:30ZengMDPI AGDiagnostics2075-44182024-12-011513010.3390/diagnostics15010030Effect of Treatment with Progestins and Antiplatelet Agents on IVF in Women with Adenomyosis and Recurrent Implantation FailureIrina Pacu0Nikolaos Zygouropoulos1Giorgia Zampieri2Aida Petca3Mircea Octavian Poenaru4Cringu Antoniu Ionescu5Department of Obstetrics & Gynecology, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Obstetrics & Gynecology, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Obstetrics & Gynecology, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Obstetrics & Gynecology, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Obstetrics & Gynecology, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment of Obstetrics & Gynecology, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, Romania<b>Background:</b> This prospective study aims to identify the effect of the dienogest 2 mg/day and aspirin 150 mg/day combined treatment for two months before frozen ET on the assisted reproduction outcome in women with adenomyosis and recurrent implantation failure (RIF). <b>Methods:</b> Patients were selected based on specific criteria and divided into two groups (with and without treatment). Preimplantation biochemical parameters and ultrasonographic features (endometrial thickness, uterine peristalsis, and junctional zone thickness) were compared with pregnancy rate in a non-natural cycle frozen embryo transfer technique. A comparison between the two study groups indicated an increased successful implantation rate and clinical pregnancy rate (25% vs. 7.4%). <b>Results</b>: These results were attributed to the reduced uterine peristalsis and the reduction in thickness of the junctional zone following treatment. Available data were limited due to the nature of the study though maximal effort was exerted for the selected patients between groups to be as demographically similar and free from other potential pathology that may affect the results. <b>Conclusions:</b> In conclusion, it appears that the above stated treatment improves outcomes in women with adenomyosis and RIF; the parameters used may provide an insight as to the reasons why this occurs, though an explanation of the molecular mechanisms is still elusive.https://www.mdpi.com/2075-4418/15/1/30adenomyosisrecurrent implantation failurejunctional zoneuterine peristaltic wave
spellingShingle Irina Pacu
Nikolaos Zygouropoulos
Giorgia Zampieri
Aida Petca
Mircea Octavian Poenaru
Cringu Antoniu Ionescu
Effect of Treatment with Progestins and Antiplatelet Agents on IVF in Women with Adenomyosis and Recurrent Implantation Failure
Diagnostics
adenomyosis
recurrent implantation failure
junctional zone
uterine peristaltic wave
title Effect of Treatment with Progestins and Antiplatelet Agents on IVF in Women with Adenomyosis and Recurrent Implantation Failure
title_full Effect of Treatment with Progestins and Antiplatelet Agents on IVF in Women with Adenomyosis and Recurrent Implantation Failure
title_fullStr Effect of Treatment with Progestins and Antiplatelet Agents on IVF in Women with Adenomyosis and Recurrent Implantation Failure
title_full_unstemmed Effect of Treatment with Progestins and Antiplatelet Agents on IVF in Women with Adenomyosis and Recurrent Implantation Failure
title_short Effect of Treatment with Progestins and Antiplatelet Agents on IVF in Women with Adenomyosis and Recurrent Implantation Failure
title_sort effect of treatment with progestins and antiplatelet agents on ivf in women with adenomyosis and recurrent implantation failure
topic adenomyosis
recurrent implantation failure
junctional zone
uterine peristaltic wave
url https://www.mdpi.com/2075-4418/15/1/30
work_keys_str_mv AT irinapacu effectoftreatmentwithprogestinsandantiplateletagentsonivfinwomenwithadenomyosisandrecurrentimplantationfailure
AT nikolaoszygouropoulos effectoftreatmentwithprogestinsandantiplateletagentsonivfinwomenwithadenomyosisandrecurrentimplantationfailure
AT giorgiazampieri effectoftreatmentwithprogestinsandantiplateletagentsonivfinwomenwithadenomyosisandrecurrentimplantationfailure
AT aidapetca effectoftreatmentwithprogestinsandantiplateletagentsonivfinwomenwithadenomyosisandrecurrentimplantationfailure
AT mirceaoctavianpoenaru effectoftreatmentwithprogestinsandantiplateletagentsonivfinwomenwithadenomyosisandrecurrentimplantationfailure
AT cringuantoniuionescu effectoftreatmentwithprogestinsandantiplateletagentsonivfinwomenwithadenomyosisandrecurrentimplantationfailure